Leiomyosarcoma differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) No edit summary |
||
Line 57: | Line 57: | ||
* Extensive [[necrosis]] and [[hemorrhage]] | * Extensive [[necrosis]] and [[hemorrhage]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Features such as tumor localization, irregular or nodular margins, necrosis, rapid growth, intense contrast enhancement, and restriction at diffusion-weighted imaging can suggest the diagnosis and help differentiate from more common | * Features such as tumor localization, irregular or nodular margins, [[necrosis]], rapid growth, intense contrast enhancement, and restriction at [[diffusion-weighted imaging]] can suggest the diagnosis and help differentiate from more common [[leiomyoma]]<nowiki/>s and endometrial carcinoma. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''Gross histology:''' | * '''Gross histology:''' | ||
* Large, solitary, poorly circumscribed masses (average 10 cm) | * Large, solitary, poorly circumscribed masses (average 10 cm) | ||
* Typically display a fleshy variegated cut surface with areas of hemorrhage or necrosis | * Typically display a fleshy variegated cut surface with areas of hemorrhage or necrosis | ||
| style="background: #F5F5F5; padding: 5px;" |Histology and biopsy | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Histology]] and [[biopsy]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women with sarcoma vs women with fibroids, tend to be older | * Women with sarcoma vs women with fibroids, tend to be older | ||
Line 86: | Line 87: | ||
* [[Bcl-2]] expression is more frequent and strong marker in leiomyomas compared with leiomyosarcoma. | * [[Bcl-2]] expression is more frequent and strong marker in leiomyomas compared with leiomyosarcoma. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Enlarged [[uterus]] with multiple whorled mass lesions, largest of size 8.6×7.1 cm, not extending into the abdomen | * Enlarged [[uterus]] with multiple whorled mass lesions, largest of size 8.6×7.1 cm, not extending into the [[abdomen]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* An enlarged uterus and a deformed uterine contour are the most common CT findings of leiomyomas | * An enlarged uterus and a deformed uterine contour are the most common [[CT]] findings of leiomyomas | ||
* Leiomyomas usually have a uniformly solid consistency | * Leiomyomas usually have a uniformly solid consistency | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
'''T2-weighted MRI''': | '''T2-weighted [[MRI]]''': | ||
* Hypointense masses | * Hypointense masses | ||
* Homogeneous | * Homogeneous | ||
Line 97: | Line 98: | ||
* Red degeneration | * Red degeneration | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Abscence of cytologic atypia | * Abscence of cytologic [[atypia]] | ||
* Mild nuclear atypia, up to 10-20 mitosis | * Mild nuclear atypia, up to 10-20 [[mitosis]] | ||
* No tumor cell necrosis | * No tumor cell necrosis | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy and histology | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Biopsy]] and histology | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 128: | Line 130: | ||
* Hypointense masses | * Hypointense masses | ||
| style="background: #F5F5F5; padding: 5px;" |'''On microscopic analysis:''' | | style="background: #F5F5F5; padding: 5px;" |'''On microscopic analysis:''' | ||
* Zones of recent hemorrhage within nodules of hypercellular smooth muscle. | * Zones of recent [[hemorrhage]] within nodules of hypercellular [[smooth muscle]]. | ||
* Coagulative necrosis (red degeneration) | * [[Coagulative necrosis]] (red degeneration) | ||
* Mitotic figure not exceeding 2/10 HPF, mostly located in the perihemorrhagic areas '''On gross examination:''' | * Mitotic figure not exceeding 2/10 HPF, mostly located in the perihemorrhagic areas '''On gross examination:''' | ||
* Features of multiple hemorrhagic area | * Features of multiple hemorrhagic area | ||
* [[Necrosis]] | * [[Necrosis]] | ||
* Cyst formation | * [[Cyst]] formation | ||
* Softening, or color different than the usual leiomyoma | * Softening, or color different than the usual leiomyoma | ||
| style="background: #F5F5F5; padding: 5px;" |Biopsy specimen and histology | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Biopsy]] specimen and [[histology]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 163: | Line 166: | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Biopsy | * [[Biopsy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Association with lymphangiomyomatosis and tuberous sclerosis | * Association with [[lymphangiomyomatosis]] and [[tuberous sclerosis]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Epitheloid [[angiosarcoma]]'''<ref>{{cite journal|doi=10.1043/1543-2165-135.2.268.}}</ref><ref name="HwangLim2013">{{cite journal|last1=Hwang|first1=Jae Pil|last2=Lim|first2=Sang Moo|title=Uterine Epithelioid Angiosarcoma on F-18 FDG PET/CT|journal=Nuclear Medicine and Molecular Imaging|volume=47|issue=2|year=2013|pages=134–137|issn=1869-3474|doi=10.1007/s13139-013-0191-y}}</ref><ref name="ChenFirth2018">{{cite journal|last1=Chen|first1=Innie|last2=Firth|first2=Bianca|last3=Hopkins|first3=Laura|last4=Bougie|first4=Olga|last5=Xie|first5=Ri-hua|last6=Singh|first6=Sukhbir|title=Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids|journal=JSLS : Journal of the Society of Laparoendoscopic Surgeons|volume=22|issue=1|year=2018|pages=e2017.00066|issn=1086-8089|doi=10.4293/JSLS.2017.00066}}</ref> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Epitheloid [[angiosarcoma]]'''<ref>{{cite journal|doi=10.1043/1543-2165-135.2.268.}}</ref><ref name="HwangLim2013">{{cite journal|last1=Hwang|first1=Jae Pil|last2=Lim|first2=Sang Moo|title=Uterine Epithelioid Angiosarcoma on F-18 FDG PET/CT|journal=Nuclear Medicine and Molecular Imaging|volume=47|issue=2|year=2013|pages=134–137|issn=1869-3474|doi=10.1007/s13139-013-0191-y}}</ref><ref name="ChenFirth2018">{{cite journal|last1=Chen|first1=Innie|last2=Firth|first2=Bianca|last3=Hopkins|first3=Laura|last4=Bougie|first4=Olga|last5=Xie|first5=Ri-hua|last6=Singh|first6=Sukhbir|title=Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids|journal=JSLS : Journal of the Society of Laparoendoscopic Surgeons|volume=22|issue=1|year=2018|pages=e2017.00066|issn=1086-8089|doi=10.4293/JSLS.2017.00066}}</ref> | ||
Line 183: | Line 186: | ||
* Nonspecific | * Nonspecific | ||
* Bulky or normal size uterus | * Bulky or normal size [[uterus]] | ||
* Intratumoral blood flow on [[Doppler]] | * Intratumoral blood flow on [[Doppler]] | ||
Line 191: | Line 194: | ||
* Focal areas of high signal intensity, known as the “cauliflower-like appearance” on gadolinium-enhanced [[MRI]] | * Focal areas of high signal intensity, known as the “cauliflower-like appearance” on gadolinium-enhanced [[MRI]] | ||
| style="background: #F5F5F5; padding: 5px;" |'''Microscopic histology:''' | | style="background: #F5F5F5; padding: 5px;" |'''Microscopic histology:''' | ||
* Nodules, and trabeculae of infiltrative epithelioid to spindled cells | * [[Nodules]], and trabeculae of infiltrative epithelioid to spindled cells | ||
* Eosinophilic [[cytoplasm]]. | * Eosinophilic [[cytoplasm]]. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Biopsy]] and histology | * [[Biopsy]] and [[histology]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Epithelioid angiosarcoma has a male predilection | * Epithelioid [[angiosarcoma]] has a male predilection | ||
* Most often arises in the deep soft | * Most often arises in the deep [[soft tissue]]<nowiki/>s (usually intramuscular) of the extremities, but a variety of primary sites, including the [[thyroid gland]] can be involved. | ||
* Early nodal and solid organ metastasis, especially to the [[lungs]], [[bone]], [[soft tissue]], and [[skin]]. | * Early nodal and solid organ [[metastasis]], especially to the [[lungs]], [[bone]], [[soft tissue]], and [[skin]]. | ||
|} | |} | ||
Revision as of 18:06, 14 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Leiomyosarcoma must be differentiated from other soft tissue tumors, some variants of leimyoma resembles malignant tumor. Other possible differential diagnosis of leimyosarcoma include, epithelioid endometrial stromal sarcoma, epithelioid angiosarcoma.
Differentiating Leiomyosarcoma from other Diseases
The table below summarizes the findings that differentiate Leiomyosarcoma from other conditions that may cause similar signs and symptoms.[1][2][3]
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||
---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||
Lab Findings | Imaging | Histology | |||||||
Ultrasound | CT scan | MRI | |||||||
Uterine Leiomyosarcoma[4][5][6] |
|
|
|
|
|
|
|
| |
Leiomyoma (mitotically active type)[7][8][9][10][11][12] |
|
|
T2-weighted MRI:
enhancement
|
|
|
||||
Hemorrhagic cellular leiomyomas (apoplectic leiomyoma)[13][14] |
|
|
|
|
T2-weighted MRI:
|
On microscopic analysis:
|
|||
PEComa[15][16][17] |
|
|
|
|
|
|
Microscopic analysis:
|
| |
Epitheloid angiosarcoma[18][19][20] |
|
|
|
|
|
T2-weighted MRI:
|
Microscopic histology: |
|
References
- ↑ Cotton PB, Shorvon PJ (1984) Analysis of endoscopy and radiography in the diagnosis, follow-up and treatment of peptic ulcer disease. Clin Gastroenterol 13 (2):383-403. PMID: 6378443
- ↑ Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218 (5):583-92. PMID: 8239772
- ↑ Kimura T, Kamiura S, Yamamoto T, Seino-Noda H, Ohira H, Saji F (2004) Abnormal uterine bleeding and prognosis of endometrial cancer. Int J Gynaecol Obstet 85 (2):145-50. DOI:10.1016/j.ijgo.2003.12.001 PMID: 15099776
- ↑ Santos, Pedro; Cunha, Teresa Margarida (2015). "Uterine sarcomas: clinical presentation and MRI features". Diagnostic and Interventional Radiology. 21 (1): 4–9. doi:10.5152/dir.2014.14053. ISSN 1305-3825.
- ↑ Hata, Kohkichi; Hata, Toshiyuki; Makihara, Ken; Aoki, Showa; Takamiya, Osamu; Kitao, Manabu; Harada, Yuji; Nagaoka, Saburo (1990). "Sonographic Findings of Uterine Leiomyosarcoma". Gynecologic and Obstetric Investigation. 30 (4): 242–245. doi:10.1159/000293278. ISSN 1423-002X.
- ↑ Rha, Sung Eun; Byun, Jae Young; Jung, Seung Eun; Lee, Soo Lim; Cho, Song Mee; Hwang, Seong Su; Lee, Hae Giu; Namkoong, Sung-Eun; Lee, Jae Mun (2003). "CT and MRI of Uterine Sarcomas and Their Mimickers". American Journal of Roentgenology. 181 (5): 1369–1374. doi:10.2214/ajr.181.5.1811369. ISSN 0361-803X.
- ↑ Woźniak, Andrzej; Woźniak, Sławomir (2017). "Ultrasonography of uterine leiomyomas". Menopausal Review. 16 (4): 113–117. doi:10.5114/pm.2017.72754. ISSN 1643-8876.
- ↑ Bodner, Klaus; Bodner-Adler, Barbara; Kimberger, Oliver; Czerwenka, Klaus; Mayerhofer, Klaus (2016). "Bcl-2 Receptor Expression in Patients With Uterine Smooth Muscle Tumors: An Immunohistochemical Analysis Comparing Leiomyoma, Uterine Smooth Muscle Tumor of Uncertain Malignant Potential, and Leiomyosarcoma". Journal of the Society for Gynecologic Investigation. 11 (3): 187–191. doi:10.1016/j.jsgi.2003.10.003. ISSN 1071-5576.
- ↑ Adaikkalam J (April 2016). "Lipoleiomyoma of Cervix". J Clin Diagn Res. 10 (4): EJ01–2. doi:10.7860/JCDR/2016/16505.7531. PMID 27190823.
- ↑ Houser, L. Murray; Carrasco, C. H.; Sheehan, C. R. (1979). "Lipomatous tumour of the uterus: radiographic and ultrasonic appearance". The British Journal of Radiology. 52 (624): 992–993. doi:10.1259/0007-1285-52-624-992. ISSN 0007-1285.
- ↑ Keriakos, Remon; Maher, Mark (2013). "Management of Cervical Fibroid during the Reproductive Period". Case Reports in Obstetrics and Gynecology. 2013: 1–3. doi:10.1155/2013/984030. ISSN 2090-6684.
- ↑ Coronado GD, Marshall LM, Schwartz SM (May 2000). "Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study". Obstet Gynecol. 95 (5): 764–9. PMID 10775744.
- ↑ Myles JL, Hart WR (November 1985). "Apoplectic leiomyomas of the uterus. A clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage". Am. J. Surg. Pathol. 9 (11): 798–805. PMID 4073354.
- ↑ . doi:10.1097/PAS.0000000000000569. Check
|doi=
value (help). Missing or empty|title=
(help) - ↑ Tan, Y.; Zhang, H.; Xiao, E.-H. (2013). "Perivascular epithelioid cell tumour: Dynamic CT, MRI and clinicopathological characteristics—Analysis of 32 cases and review of the literature". Clinical Radiology. 68 (6): 555–561. doi:10.1016/j.crad.2012.10.021. ISSN 0009-9260.
- ↑ Kang, Jeong Ba; Seo, Jin Won; Park, Young-Han; Jang, Pong Rheem (2014). "Malignant Perivascular Epithelioid Cell Tumor of the Uterus with Lung Metastasis". The Korean Journal of Pathology. 48 (6): 454–457. doi:10.4132/KoreanJPathol.2014.48.6.454. ISSN 1738-1843.
- ↑ "PEComa of the Uterus: A Rare Mesenchymal Tumor Displaying a ≪Snowstorm≫ Pattern at Magnetic Resonance Imaging". Journal of the Belgian Society of Radiology. 100 (1). 2016. doi:10.5334/jbr-btr.926. ISSN 1780-2393.
- ↑ . doi:10.1043/1543-2165-135.2.268. Check
|doi=
value (help). Missing or empty|title=
(help) - ↑ Hwang, Jae Pil; Lim, Sang Moo (2013). "Uterine Epithelioid Angiosarcoma on F-18 FDG PET/CT". Nuclear Medicine and Molecular Imaging. 47 (2): 134–137. doi:10.1007/s13139-013-0191-y. ISSN 1869-3474.
- ↑ Chen, Innie; Firth, Bianca; Hopkins, Laura; Bougie, Olga; Xie, Ri-hua; Singh, Sukhbir (2018). "Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids". JSLS : Journal of the Society of Laparoendoscopic Surgeons. 22 (1): e2017.00066. doi:10.4293/JSLS.2017.00066. ISSN 1086-8089.